CCL18 and diffuse large B-cell lymphoma: Together, these results demonstrate that both MAPK10 and CCL18 overexpression are linked to unfavorable clinical outcomes in DLBCL, with the adverse prognostic effect of CCL18 being particularly pronounced in the ABC subtype.